TokenPost topic
AbbVie
8 TokenPost stories are tagged AbbVie. The newest appear first.
Latest AbbVie stories
- AbbVie Agrees to Pay Up to $2.54 Billion in DISCO Pharmaceuticals Collaboration
The companies will collaborate on developing novel cancer treatments, expanding AbbVie’s work in next-generation therapies.
· Business
- AbbVie Raises Full-Year Guidance as Non-GAAP EPS Beats Estimates
Third-quarter revenue reached $17.4 billion, up 10.3% year over year, while the immunology portfolio generated $9.165 billion in global net revenue.
· Business
- AbbVie Raises Quarterly Dividend 5.2% to $1.82 Per Share
The increase lifts the payout from $1.73. Jan. 15 is both the record and ex-dividend date, with payment scheduled for Feb. 16.
· Business
- Five Companies Expected to Report Earnings Before Friday’s Open
The named companies are ExxonMobil, Chevron, AbbVie, BP and Cameco, with reports on the calendar for Oct. 30.
· Business
- AbbVie Q3 Preview Centers on $3.77 Earnings Per Share Estimate
AbbVie is scheduled to report before U.S. markets open Friday, Oct. 30. Wall Street analysts expect Skyrizi and Rinvoq to drive the quarter.
· Business
- AbbVie Seeks FDA Review of Etentamig for Relapsed or Refractory Myeloma
In Phase 3 CERVINO, the response rate was 74.0% with etentamig and 45.7% with standard therapy after a median 11.4 months of follow-up.
· Regulation
- Bybit to List Stock Perpetuals for AbbVie, TTM Technologies and Axe Compute
The three contracts are scheduled to begin trading on Oct. 26, each with leverage of up to 25x.
· Business
- Iambic Therapeutics Plans Nasdaq IPO Above $800 Million Valuation
The Nvidia- and AbbVie-backed life sciences company plans to list under the ticker IAM and leverages artificial intelligence.
· Business